ID3 enhances PD-L1 expression by restructuring MYC to promote colorectal cancer immune evasion
Proceedings of the National Academy of Sciences · 15.04.2025 · 122 (15)
DOI: 10.1073/pnas.2423490122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 10.04.2025. Verfasst von Chuanzhong Huang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fujian Medical University, Fuzhou 350014, People's Republic of China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, B7-H1 Antigen, Inhibitor of Differentiation Proteins, Proto-Oncogene Proteins c-myc. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC).
Abstract (Originalsprache)
The inhibitor of DNA binding protein ID3 has been associated with the progression of colorectal cancer (CRC). Despite its significance, its specific role in the immune evasion strategies utilized by CRC remains unclear. RNA-seq analysis revealed that ID3 was positively associated with the PD-L1 immune checkpoint. We further demonstrated that tumor cell–expressed ID3 enhanced PD-L1 expression, suppressed the infiltration and activation of CD8 + T cells, and facilitated the immune evasion of CRC cells. Additionally, we found that knockdown of ID3 significantly enhanced the effectiveness of PD-L1 antibody blockade treatment in combating CRC, reduced the upregulation of PD-L1 induced by the antibody, and altered the immune microenvironment within CRC. Mechanistically, ID3 interacted with the transcription factor MYC and reconstructed the four-dimensional structure of MYC, thereby enhancing its binding affinity to the PD-L1 promoter and augmenting PD-L1 transcriptional activity. By integrating analysis of ChIP-seq, RNA-seq, and ImmPort gene sets, we found that ID3’s DNA-assisted binding function was widespread and could either enhance or suppress gene transcription, not only affecting tumor immune escape through immune checkpoints but also regulating various cytokines and immune cells involved in tumor immunity. In conclusion, our study uncovers a mechanism by which ID3 promotes immune evasion in CRC and implicates that targeting ID3 may improve the efficacy of anti-PD-1/PD-L1 immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fujian Medical University, Fuzhou 350014, People's Republic of China.
- School of Basic Medical Sciences, Fujian Medical University, Fuzhou 350122, China.
- Fujian Provincial Key Laboratory of Translational Cancer Medicine, Fuzhou 350014, People's Republic of China.
- State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiamen 361102, People's Republic of China.
ORCID-Profile: Chuanzhong Huang, Changhua Zhuo
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
Zitieren
APA
Huang, C., Wang, L., Zhuo, C., Chen, W., Fan, H., Hong, Y., Zhang, Y., Zhou, D., Lin, W., Zhang, L., Zhao, J., Chen, S., Yu, C., & Ye, Y. (2025). ID3 enhances PD-L1 expression by restructuring MYC to promote colorectal cancer immune evasion. Proceedings of the National Academy of Sciences, 122(15). https://doi.org/10.1073/pnas.2423490122
Vancouver
Huang C, Wang L, Zhuo C, Chen W, Fan H, Hong Y, et al. ID3 enhances PD-L1 expression by restructuring MYC to promote colorectal cancer immune evasion. Proceedings of the National Academy of Sciences. 2025;122(15). doi:10.1073/pnas.2423490122
BibTeX
@article{Huang2025,
author = {Huang, Chuanzhong and Wang, Ling and Zhuo, Changhua and Chen, Wenxin and Fan, Hongmei and Hong, Yilin and Zhang, Yu and Zhou, Dongmei and Lin, Wansong and Zhang, Lingyu and Zhao, Jingjing and Chen, Shuping and Yu, Chundong and Ye, Yunbin},
title = {ID3 enhances PD-L1 expression by restructuring MYC to promote colorectal cancer immune evasion},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
volume = {122},
number = {15},
doi = {10.1073/pnas.2423490122}
}
EUVIMED